NILOTINIB

NILOTINIB CAPSULES 200 MG

Indication

Newly Diagnosed Philadelphia chromosome-positive Chronic Myelogenous (CML) in the chronic phase. Chronic phase and accelerated phase Philadelphia chromosome-positive CML with resistance or intolerance to prior therapy including imatinib.

Pack

1 x 10's Alu Alu
Category:

Note: Products are not marketed in countries where it is protected by Patent Law